Vaccines & Vaccinations

Dr. Patel is the Senior Director of Product Development at Emergent Biosolutions (USA). He is responsible for developing oral and injectabledelivery platforms and process for vaccines. He has developed process, formulation and delivery system for small molecules, DNA vaccines, Virus Like Particle vaccines (VLP), cell therapy, Adenovirus and Bacterial vaccines from development to GMP manufacturing.

Dr. Patel CMC experience ranges from pre-clinical to life cycle management with successful track record of commercialization of the biologics. He has been an integral part of the QA, QC and GMP manufacturing teams where he has developed over 15 clinical products and trained theGMP staff on the production technology. Prior to PaxVax, Dr. Patel worked as a Senior Scientist II, doing Formulation Research at NexBio Inc. and as a Sr. Scientist at MicroIslet, Inc where his primary responsibilities involved developing process and formulations for encapsulating cells (islets) for in vivotransplantation. Dr. Patel received his Ph.D. and M.S. in Chemical Engineering with special interest in Nanotechnology field, from Louisiana Tech University, and, B.S. Chemical Engineering from University of Poona (India)

Dr. Ruan is the Sr. Director of process development and production at Emergent Biosolutions (USA). She has extensive experience in bioprocess development from preclinical to licensure. She has a Ph.D. degree in biochemical engineering from South China University of Science and Technology.

She managed Process development, clinical production (Phase I, Phase II, and Phase III), facilities, materials management, validation, Tech Transfer and CMO. Dr. Ruan is responsible for developing and manufacturing oral delivery vectors and injectable virus-like-particles for vaccines, as well as researching, evaluating, and optimizing new technology platforms to improve the production scale and stability of the products.

Ayoub Bazzaz has completed his PhD at the age of 30 years from Nottingham University, UK and continued postdoctoral research works for over 10 years at Leeds, Liverpool and Cardiff Universities in UK.

He is one of the founder of Faculty of Medicine of Tikrit University, Iraq and first head of Anatomy department 1988-1991. Has supervised and refereed many PhD and MSc students in Iraq, KSA, Libya and UK and has over 60 published scientific papers in reputed International journals.

Jeanne Moldenhauer, Vice-President of Excellent Pharma Consulting has more than 30 years’ experience in the pharmaceutical industry.

She chaired the Environmental Monitoring/Microbiology Interest Group of PDA for more than 15 years, served on the Scientific Advisory Board of PDA for 20 years, founded the Rapid Microbiology User’s Group™, and is a Member of ASQ and RAPS. She is the author of many books and numerous publications (book chapters and magazine articles)

Leandro Resende has completed his PhD at the age of 38 years from Paulista State University, Botucatu – SP, Brazil. He is currently the technical responsible for the oncology gynaecology department of the Base Hospital of the Federal District in Brasília – DF, Brazil.

He has published articles with an emphasis on oncology gynaecology and lectures at international congresses about the HPV vaccination program in Brazil.

Kubar Olga, MD, PhD is the Leading Researcher in the Laboratory of Etiology and Control of Viral Infections in St.Petersburg Pasteur Institute. During many years Olga Kubar is responsible for the research connected with the study ethical aspects of infectious diseases and vaccination. As ex-member of IBC UNESCO she took part in developing of the several international documents on bioethics. She is the Board-member of EFGCP responsable for education and the member of Russian National Committee on Bioethics in UNESCO Commision of Russia.

She published more than 100 papers in reputed journals and 9 Books on Bioethics and Infectious Diseases.